Hesbiphar SA
0.2 FTEHesbiphar reported total assets of 255,869 € at the end of the 2025 financial year (annual accounts filed with the NBB on 10 Aug 2026), with 0.2 full-time equivalent.
The score of Hesbiphar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -21 % Total assets -28 % Headcount (avg FTE) -33 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Hesbiphar's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −16,990 € | ||||
| Equity | 255,713 € | ||||
| Cash | 21,708 € | ||||
| EBITDA | 4,369 € | ||||
| Total assets | 255,869 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Aug 2026
- Year ended 31 Dec 2024filed on 20 Aug 2025
- Year ended 31 Dec 2023filed on 23 Aug 2024
- Year ended 31 Dec 2022filed on 19 Jun 2023
- Year ended 31 Dec 2021filed on 09 Sep 2022
Hesbiphar's financial analysis
- Solvency99.9%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Hesbiphar
Hesbiphar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0456.579.592
- VAT number
- BE0456579592
- Peppol
- Registered · 0208:0456579592 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 08 Dec 1995
- Registered office
- 4280 Hannut
- Size
- Micro · 0.2 FTE
- Latest accounts
- 2025 · filed on 10 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Hesbiphar (SA) has been based in Hannut since 1995, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 16,990 € and equity of 255,713 €; its revenue is not published. With 0.2 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 99.9%, above the median of its sector (41.5%).
Companies similar to Hesbiphar
Companies in the same business, of comparable size and area, outside its group.
- Medphar Retail sale of pharmaceutical products Schaerbeek · balance sheet 255,858 €
- Pharma VAL Retail sale of pharmaceutical products Profondeville · balance sheet 255,460 €
- Odepharma Retail sale of pharmaceutical products Koksijde · balance sheet 255,295 €
- Pharmacie Merelle Retail sale of pharmaceutical products Quévy · balance sheet 256,663 €
- MaPharma Retail sale of pharmaceutical products Charleroi · balance sheet 256,730 €
- Pharmadeville Retail sale of pharmaceutical products Bernissart · balance sheet 257,934 €
- Yasmin Libbrecht Retail sale of pharmaceutical products Antwerp · balance sheet 258,250 €
- Apotheek Van de Peer Sabine Retail sale of pharmaceutical products Edegem · balance sheet 258,424 €
Frequently asked questions about Hesbiphar
What is the revenue of Hesbiphar?
Hesbiphar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Hesbiphar?
In Belgium, the VAT number is the company number prefixed with BE: BE0456579592 for Hesbiphar, if the company is VAT-registered. Its company number (CBE) is 0456.579.592.
Where is the registered office of Hesbiphar?
According to the CBE register, the registered office of Hesbiphar is in 4280 Hannut.
What is the equity of Hesbiphar?
At the close of the 2025 financial year, the equity of Hesbiphar amounts to 255,713 €, a solvency of 99.9% of total assets.
How many people work at Hesbiphar?
0.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Hesbiphar?
The register lists 6 active mandates at Hesbiphar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Hesbiphar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →